Shai Izraeli

Prof Izraeli is the Director of the Pediatric Hematology Oncology Division at the Schneider Children’s Medical Center of Israel.  He is also the Shapiro professor and the head of the Dotan center for research of hematological malignancies in Tel Aviv University and an adjucnt research professor at the department of systems biology at the Beckman Institute at City of Hope, Duarte CA, USA. He is a founding member of the Israel National Academy of Scientific Medicine.
Prof Izraeli is a member of the executive committee and the chair of hematological malignancies in the ITCC (Innovative Therapeutics of Childhood Cancer) the European organization for promotion of clinical trials of new drugs for children with cancer by either the pharmaceutical and biotech industries or academia. He has been the Treasurer, Chair of the Research Committee and a member of the Executive Board or the European Hematology Association. He received the prestigous mentorship and education award  of the European Hematology Association for his multi-year support of the carreer of young hematologists and researchers in the field of blood diseases and cancer. His major research interest is in hematological malignancies and their predisposition syndromes. The research or Down Syndrome leukemia research have led to discoveries translated to novel cancer diagnostics and therapies. He published more than 200 peer reviewed scientific publications, has been supported by multiple international research grants and has many international colloaborations.